Items where authors include "Howell, A"

Export as [feed] Atom [feed] RSS
Number of items: 18.

Article

Keir, HR, Long, MB, Abo-Leyah, H et al. (192 more authors) (2022) Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine, 10 (12). pp. 1119-1128. ISSN 2213-2600

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Dennis, J, Tyrer, JP, Walker, LC et al. (121 more authors) (2022) Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5. 65. ISSN 2399-3642

Ahearn, TU, Zhang, H, Michailidou, K et al. (202 more authors) (2022) Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research, 24 (1). 2.

Morra, A, Escala-Garcia, M, Beesley, J et al. (175 more authors) (2021) Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research, 23 (1). 86.

Smith, SG orcid.org/0000-0003-1983-4470, Sestak, I, Morris, MA orcid.org/0000-0002-9325-619X et al. (4 more authors) (2021) The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies. Breast Cancer Research and Treatment, 188 (1). pp. 215-223. ISSN 0167-6806

Johnson, N, Maguire, S, Morra, A et al. (145 more authors) (2021) CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4). pp. 842-854. ISSN 0007-0920

Kramer, I, Hooning, MJ, Mavaddat, N et al. (264 more authors) (2020) Breast cancer polygenic risk score and contralateral breast cancer risk. The American Journal of Human Genetics, 107 (5). pp. 837-848. ISSN 0002-9297

Zhang, H, Ahearn, TU, Lecarpentier, J et al. (269 more authors) (2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics, 52 (6). pp. 572-581. ISSN 1061-4036

Escala-Garcia, M, Abraham, J, Andrulis, IL et al. (142 more authors) (2020) A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications, 11 (1). 312.

Fachal, L, Aschard, H, Beesley, J et al. (338 more authors) (2020) Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1). pp. 56-73. ISSN 1061-4036

Shu, X, Wu, L, Khankari, NK et al. (203 more authors) (2019) Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis. International Journal of Epidemiology, 48 (3). pp. 795-806. ISSN 0300-5771

Mavaddat, N, Michailidou, K, Dennis, J et al. (266 more authors) (2019) Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. The American Journal of Human Genetics, 104 (1). pp. 21-34. ISSN 0002-9297

Sestak, I, Smith, SG orcid.org/0000-0003-1983-4470, Howell, A et al. (2 more authors) (2018) Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II. Annals of Oncology, 29 (2). pp. 504-509. ISSN 0923-7534

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Smith, SG orcid.org/0000-0003-1983-4470, Sestak, I, Howell, A et al. (2 more authors) (2017) Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I). Journal of Clinical Oncology, 35 (23). pp. 2666-2673. ISSN 0732-183X

Conference or Workshop Item

Smith, SG orcid.org/0000-0003-1983-4470, Sestak, I, Morris, MA orcid.org/0000-0002-9325-619X et al. (3 more authors) (2018) Overweight and breast cancer risk in the International Breast Cancer Intervention studies I and II. In: ASCO Annual Meeting 1, 01-05 Jun 2018.

Proceedings Paper

Sestak, I, Smith, S orcid.org/0000-0003-1983-4470, Sleeth, M et al. (2 more authors) (2018) Participant-reported symptoms as predictors of long-term adherence of endocrine therapy in the International breast cancer intervention studies 2 (IBIS-2). In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas. American Association for Cancer Research .

This list was generated on Sat Mar 23 22:21:48 2024 GMT.